New paper by Dr. Francesco Bertoni lab

news on 6 Feb , 2019
A new study led by Francesco Bertoni in collaboration with Francesco Forconi from the University of Southampton provides novel insights in the pathogenesis of hairy cell leukemia. Classic hairy cell leukemia (HCL) is a rare mature B cell tumor that is characterized by the acquisition of the BRAF V600E mutation, which leads to constitutive BRAF-MEK-ERK pathway activation and represents an effect...
More

New paper by Dr. Francesco Bertoni Lab

news on 28 Jan , 2019
Inhibition of Bruton's tyrosine kinase (BTK) is a well-established therapeutic approach in B-cell malignancies and two BTK inhibitors, ibrutinib and acalabrutinib, have been approved by the U.S. Food and Drug Administration (FDA). In this new work by Bertoni’s lab and published on Haematologica, Chiara Tarantelli and colleagues studied an investigational second generation irreversible BTK inhibito...
More

New Publication by Dr. Bertoni

news on 2 Jan , 2019
A publication in the Haematologica journal by Dr. Bertoni in collaboration with Prof. Luca Aresu of the Department of Veterinary Sciences from the University of Turin has paved the way to a new approach in biomedical research, highlighting the importance of the use of the dog as comparative and pre-clinical model in oncology medicine. Authors provide brand new data on transcriptomic, methylation a...
More

Lecture Series of the PhD program “New approaches to the treatment of cancer”

news on 30 Nov , 2018
Lecture of our International PhD Program in Cancer Biology and Oncology of USI (2018/2019) Prof. René Bernards, Netherlands Cancer Institute, Amsterdam, Netherlands IRB Conference Room Via V. Vela 6, Bellinzona  Monday 3 December 2018,  4.00pm Contact: Andrea Alimonti, andrea.alimonti@ior.usi.ch Supported by: IBSA Foundation for scientific research
More

Support the Movember Foundation

news on 26 Nov , 2018
Join Dr. Jean-Philippe Theurillat and support the Movember Foundation. Donate online at https://mobro.co/13929704 until 30th November 2018. Your donations will help stop men dying too young. Learn more about Movember: https://ch.movember.com/en/
More